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Abstract Class IV alcohol dehydrogenase (ADH) is a form preferentially expressed in stomach. We report here the isolation and sequence 
determination of a novel human ADH gene (ADH7). Phylogenetic analysis trongly suggests that ADH7 is a functional class IV ADH gene. 
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1. Introduction 
Human alcohol dehydrogenases (ADHs) are dimeric metal- 
loenzymes and had been grouped early into three classes, I - I I I ,  
according to different electrophoretic properties and different 
substrate specificities (e.g., see [1]). These ADHs  have been 
conserved among diverse species uch as mammals, plants and 
yeasts [2,3]. Additional ADH classes IV [4] and V [5] have since 
then discovered. Phylogenetic analysis of available amino acid 
sequences has shown that class I and V are most closely related, 
their common ancestor diverged from the ancestor of class II, 
and their common ancestor diverged from the ancestor of class 
III before that ([6]; see also [7]). 
At present, mammalian class IV and V ADHs  are relatively 
poorly understood. The class V protein has been deduced from 
genomic and cDNA clones [5], but the protein has not been 
isolated from natural sources. The class IV protein appears to 
be expressed mainly in the stomach mucosa [4, 8]. The molecu- 
lar structure of a class IV protein from rat has been character- 
ized only recently [8], but that for human is not known. We 
report here the cloning and sequencing of  a novel human ADH 
gene (ADH7). Phylogenetic analysis of the amino acid sequence 
deduced from ADH7 and other vertebrate ADHs  strongly sug- 
gests that ADH7 is a functional class IV ADH gene. 
2. Materials andmethods 
2.1. ~ clone characterization a d DNA sequencing 
Two sets of human genomic DNA libraries were constructed using 
genomic DNA partially digested with Sau3A or EcoRI and by ligating 
it with 2EMBL3 or 2EMBL4 DNA, respectively (e.g. see [9]). To 
characterize a novel ADH gene, ADH7, two overlapping clones 21.1 
'and 218 have been obtained. 218 was isolated from the 2EMBL4 
library using bADH cDNA probe [10]. 21.1 was isolated from the 
2EMBL3 library using a 0.5 kb fragment encompassing exons 3 and 
4 of 218 as a probe. 21.1 contained exons 2-8, while 218 contained 
exons 1-5 (Fig. 1). The two clones were verified to be overlapping by 
restriction enzyme analysis and sequencing. By amplifying enomic 
DNA using a primer 100 bp from the end of 21.1 and a degenerate class 
I exon 9 primer, it became clear that exon 9 is located approximately 
1.2 kb from the end of 21.1. Furthermore, genomic Southern hybridiza- 
tion indicated that exon 9 was contained on a 2.4 kb HindlII fragment 
(data not shown). The sequence of exon 9 was obtained by using the 
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inverse PCR method [11]. To perform inverse PCR, 2 oligonucleotides 
(int8A and int8B) were designed from intron 8 sequence to flank and 
extend into the unknown genomic region upon circularization of the 
HindlII-digested genomic DNA (Fig. 1). Int8A (5'-GGCCCAAT- 
GAGTGAAAGTCATTTC-3') corresponds to sequence 100 bp from 
the end of 21.1 and was oriented to amplify towards exon 8. Int8B 
(5'-CTCAGATACCCTTATCAGAGTTGCG-3') corresponds to se- 
quence about 200 bp upstream from exon 9 and was oriented to amplify 
towards exon 9. Ligation of 1/tg HindlII-digested genomic DNA at a 
concentration f 2/~g/ml was done to promote monomeric circulariza- 
tion. The ligated product was amplified using int8A and int8B for 
30 cycles (94°C for 45 s, 55°C for 90 s, 72°C for 2 min). The expected 
1.2 kb product was gel isolated, blunt-ended by Klenow treatment and 
subcloned into EcoRV-digested Bluescript. Exon 9 sequence was ob- 
tained using int8B primer. Subcloning and double-stranded sequencing 
of the 21.1 and 218 were conducted as previously described [9,12,13]. 
2.2. Data analysis 
The amino acid sequence, Hsa7, deduced from ADH7 was compared 
to other vertebrate ADHs. Vertebrate ADHs considered were class I 
ADH~ (HsaA), fl (HsaB), ~ (HsaC) from human and those from ba- 
boon (PhaB), rhesus monkey (MacA), mouse (MmuA), rat (RnoA), 
quail (Cja), chicken (Gga), and frog (Rpe), and ADH-E (EcaE) and 
ADH-S (EcaS) from horse, one class II ADH from human (HsaP), class 
III ADHs from human (HsaX), mouse (MmuX), rat (RnoX) and horse 
(EcaX), and class V ADH (Hsa6) deduced from human ADH6 ([6] and 
references therein). Furthermore, ADH1 (PmaA) and ADH2 (PmalV) 
from deer mouse (Peromyscus maniculatus) [14] and class IV ADH from 
rat (RnolV) [8] were also included. 
To construct a rooted phylogenetic tree for these ADHs, ADH 1 and 
ADH2 from maize (see [6] and references therein) were used as an 
outgroup. These amino acid sequences can be aligned easily (see [6]). 
The number (K) of amino acid substitutions per site for two polypep- 
tides was estimated by K = -In (1 -p-p215), where p is the proportion 
of different amino acids between the two sequences [15]. Topology and 
branch lengths of the phylogenetic tree were evaluated by applying the 
neighbor-joining (N J) method to the K values and reliability of its 
topology was evaluated by the bootstrap analysis, as previously de- 
scribed [6]. 
3. Results and discussion 
3.1. Nucleotide sequence of ADH7 
ADH7 has 9 exons and 8 introns (Fig. 2), as in the case of 
ADH1 [13], ADH2 [12, 16], ADH3 [17], ADH4 [18], and ADH5 
[19], all of which have identical intron positions. Compared to 
these genes, ADH6 lacks exon 9, but positions of  its introns 1-7 
are identical to those of the other ADH genes [5]. The nine 
exons of ADH7 span about 22 kb and the approximate sizes 
of the introns 1-8 of ADH7 are 5.3, 0.6, 0.3, 0.1, 7.2, 1.4, 3.4, 
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Fig. 1. The genomic omposite of the human ADH7 gene determined by overlapping 2 clones and PCR amplification. The nine coding exons are 
indicated by solid boxes with an enlarged scale being provided under each 2 clone and genomic fragment used for inverse PCR amplification. 
(B) BarnHl; (E) EcoRI; and (H) HindIII. 
and 2.1 kb, respectively. The GT/AG consensus intron splice 
junct ions are conserved. 
The amino acid sequence, Hsa7, deduced f rom ADH7 con- 
sists o f  374 residues (Fig. 2). This size is similar to other ADHs ,  
i.e. 374 residues of  HsaX,  375 residues of  HsaA,  B, and C, 380 
residues of  HsaP, and 368 residues of  Hsa6. Hsa7 shows that 
Table 1 
Class IV-specific amino acid polymorphism 
functionally important  residues are conserved. They include 
amino acid residues Cys (47), His (68), and Cys (174), which 
provide l igands to one catalytic zinc atom, and amino acid 
residues Cys (98), Cys (101), Cys (104), and Cys (112), which 
provide l igands to another  catalytic zinc atom [20]. The se- 
quence conservat ion of  ADH7 is unlike the ADH5 pseudogene, 
71 80 166 196 233 251 261 263 287 317 322 343 
EcaX A G L A K Q G D G T W D 
HsaX . . . .  
RnoX - - - 
MmuX . . . . . .  
HsaP . . . . .  
PmaV T - - S - - 
Hsa6 - - Q - S 
Hsa7 T - P - M S N G V C L - 
RnolV V E P V L S T Q - C G 
Rpe H - - - A 
Gga K H - - S 
Cja K H - - S 
PmaA - - - A F E 
RnoA . . . . .  A F E 
MmuA - - - A F 
EcaS - - A F 
EcaE - - - A F - 
HsaC - A F - 
PhaB - A F 
HsaB A F 
HsaA - A F 
MmuA M - - - A F 
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1 
CAAGACAAAGACAGG ATG GGC ACT GCT GGA AAA GTAAGTGGAA 
GCA GCT GTG 
Ala Ata VaL 
GTT CGC ATT 
Vat Arg I le  
GTG ATA AAA 
Vat I re  Lys 
80 
GGA GAA GGA 
Gty Gtu GLy 
TAT CTG CCA 
Phe Leu Pro 
10 
GTT ATT AAA TGC AAA 
Vat l l e  Lys Cys Lys 
5.3 kb TATTTCTTAG 
Met Gty Thr Ata Gty Lys 
20 30 
CTT TGG GAG CAG AAG CAA CCC TTC TCC ATT GAG GAA ATA GAA GTT GCC CCA CCA AAG ACT AAA GAA 
Leu Trp Glu Gln Lys Gtn Pro Phe Set l l e  Gtu Gtu l le  Glu Vat Ala Pro Pro Lys Thr Lys Glu 
40 50 
AAG GTAAGCGTGA 0.6 kb TTGAACACAG ATT TTG GCC ACA GGA ATC TGT CGC ACA GAT GAC CAT 
Lys I re  Leu Ata Thr Gly l l e  Cys Arg Thr Asp Asp His 
60 70 
GGA ACA ATG GTG TCC AAG TTT CCA GTG ATT GTG GGA CAT GAG GCA ACT GGG ATT GTA GAG AGC ATT 
Gly Thr Met Vat Ser Lys Phe Pro Vat l i e  VaL Gly His Glu Ala Thr Gty I te  Vat Gtu Set l i e  
90 
GTG ACT ACA GTG AAA CCA G GTATATGCAG 0.3 kb TTTCCTGTAG GT GAC AAA GTC ATC CCT CTC 
Va[ Thr Thr Vat Lys Pro G ty Asp Lys Vat l i e  Pro Leu 
100 110 
CAA TGT AGA GAA TGC AAT GCT TGT CGC AAC CCA GAT GGC AAC CTT TGC ATT AGG AGC GA GTAGGTTT 
Gln Cys Arg Glu Cys Ash Ata Cys arg Asn Pro Gtu Gty Asn Leu Cys I re  Arg Ser As 
120 130 
TTT ACA TGC AAG GGG 
Phe Thr Cys Lys Gty 
CA 
AAA CCA GTC 
Lys Pro Vat 
160 
ATT GAT GAT 
I re  Asp Asp 
AAA ACT GGC 
Lys Thr Gty 
GGA GGA GTT 
Gty Gty Vat 
AAA GAC AAA 
Lys Asp Lys 
AGT GAG GTG 
Set Glu Vat 
GTAAGACCCA 
GTA GGA GTT 
Val Gly Va[ 
100 bp TATCAAACAG T ATT ACT GGT CGT GGA GTA CTG GCT GAT GGC ACC ACC AGA 
p l ie  Thr Gly Ar9 Gly Vat Leu Ata Asp Gty Thr Thr Arg 
140 150 
CAC CAC TTC ATG AAC ACC AGT ACA TTT ACC GAG TAC ACA GTG GTG GAT GAA TCT TCT GTT GCT AAG 
His His Phe Net Asn Thr Set Thr Phe Thr Gtu Tyr Thr Vat Vat Asp Glu Ser Set Vat Ala Lys 
170 180 
GCA GCT CCT CCT GAG AAA GTC TGT TTA ATT GGC TGT GGG TTT TCC ACT GGA TAT GGC GCT GCT GTT 
Ata Ala Pro Pro Gtu Lys Vat Cys Leu l le  G[y Cys Gty Phe Ser Thr Gty Tyr Gty A[a Ata Vat 
190 200 
AAG GTAAGAAACA 7.2 kb CTCTCCACAG GTC AAA CCT GGT TCC ACT TGC GTC GTC TTT GGC CTG 
Lys Va[ Lys Pro Gly Set Thr Cys Va[ Vat Phe GLy Leu 
210 220 
GGC CTG TCA GTC ATC ATG GGC TGT AAG TCA GCT GGT GCA TCT AGG ATC ATT GGG ATT GAC CTC AAC 
Gly Leu Set Vat i re  Net G[y Cys Lys Set Ata Gty Ata Set Arg l ie  l i e  Gly ILe Asp Leu Asn 
230 240 250 
TTT GAG AAG GCC ATG GCT GTA GGT GCC ACT GAG TGT ATC AGT CCC AAG GAC TCT ACC AAA CCC ATC 
Phe G[u Lys Ala Met Ata Val Gly Ate Thr Glu Cys l le  Set Pro Lys Asp Ser Thr Lys Pro l le  
260 270 
CTG TCA GAA ATG ACA GGC AAC AAC GTG GGA TAC ACG TTT GAA GTT ATT GGG CAT CTT GAA ACC ATG 
Leu Ser Gtu Met Thr Gty ASh Asn Vat Gty Tyr Thr Phe GLu Vat I re  Gly His Leu Asp Thr Met 
280 290 
1.4 kb CTCAG ATT GAT GCC CTG GCA TCC TGC CAC ATG AAC TAT GTG ACC AGC GTG GTT 
l te  Asp Ata Leu Ata Set Cys His Net Asn Tyr Vat Thr Set Vat Vat 
300 310 
CCT CCA TCA GCC AAG ATG CTC ACC TAT GAC CCG ATG TTG CTC TTC ACT GGA CGC ACA TGG AAG GGA 
Pro Pro Set Ata Lys Met Leu Thr Tyr Asp Pro Met Leu Leu Phe Thr Gty Arg Thr Trp Lys Gty 
320 330 
TGT GTC TTT 
Cys Va[ Phe 
GTG ACT GAG 
Vat Thr G[u 
GAA GGA TTT 
GtU Gly Phe 
GGA G GTCAGGAAAG 3.4 kb TTATTTGCAG GT TTG AAA AGC AGA GAT GAT GTC CCA AAA CTA 
Gly G ty  Leu Lys Set Arg Asp Asp Vat Pro Lys Leu 
340 350 
TTC CTG GCA AAG AAA TTT GAC CTG GAC CAG TIG ATA ACT CAT GTT TTA CCA TTT AAA AAA ATC AGT 
Phe Leu Ata Lys Lys Phe Asp Leu Asp Gin Leu l te  Thr His Vat Leu Pro Phe Lys Lys I re  Ser 
360 370 
GAG CTG CTC AAT TCA GGA CAA AG GTAACTGTTT 2.1 kb TACATTTCAG C ATT CGA ACG GTC 
Glu Leu Leu Asn Set Gly Gin Se r I l e  Arg Thr Val 
CTG ACG TTT TGA GATCCAAAGT 
Leu Thr Phe * 
Fig. 2. The nucleotide sequence of ADH7 and the deduced amino acid sequence. 
which contains no introns and three frameshift mutations in the 
coding region with a total of 10 internal termination codons [9]. 
The gene duplication event between ADH5 and the pseudogene 
seems to have occurred only about 3.5 million years ago and 
the pseudogene has undergone a rapid change since then. Thus, 
possessing no apparent structural defect and conservation of 
functionally important codons, ADH7 seems capable of being 
functional. 
3.2. A phylogenetic tree 
The phylogenetic tree for the Hsa7 and other vertebrate 
ADHs is shown in Fig. 3. Fig. 3 clearly shows that Hsa7 is most 
closely related to RnolV and belongs to class IV. Bootstrap 
support of the two ADHs forming one cluster is 1.0 and is 
highly reliable. Fig. 3 shows that class IV is most closely related 
to class I, their common ancestor diverged from the ancestor 
of class V, their common ancestor diverged from the ancestor 
of class II, and their common ancestor diverged from the ances- 
tor of class III, which is consistent with Fig. 1 in Yokoyama 
and Harry [6]. Bootstrap analysis hows that clusterings of the 
mammalian classes I, III, IV and V ADHs are highly reliable. 
However, the relationship between the classes I and IV in Fig. 
3 is not clear-cut and frog, chicken, and quail ADHs may be 
more closely related to the mammalian class I ADHs than to 
the class IV ADHs, reflecting the organismal relationship of the 
three species. Fig. 3 also clearly shows that recently character- 
ized ADH1 (PmaA) and ADH2 (PmaV) from deer mouse be- 
long to classes I and V, respectively. 
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Fig. 3. The rooted phylogenetic ree for the vertebrate ADHs. Branch length was estimated by the number of amino acid replacements per site. 
From Fig. 3, we can see that Hsa7 and RnolV have similar 
branch lengths after their divergence from each other, showing 
that the two proteins are evolving with similar rates. The 
branch length for Hsa7 since its divergence from RnolV is 0.07 
per site. After their divergences from the corresponding murine 
ADHs, the branch lengths for HsaA, B, and C are 0.10, 0.09, 
and 0.08 per site, respectively, while that for HsaX is 0.03. Thus, 
class IV ADHs are evolving with rates somewhere between 
those of class I and class V ADHs (see also Fig. 3) Interestingly, 
the zinc-containing ADH from Drosophila melanogaster [21] 
has been found recently and is shown to belong to the evolu- 
tionarily most conserved class III. All of these observations 
strongly suggest hat Hsa7 has had a strong functional con- 
straint against amino acid changes and that ADH7 is a func- 
tional gene. 
3.3. Characteristics of  class IV  proteins 
By comparing RnolV to other classes of ADHs, amino acid 
residues Gly (47), Ala (294), and Tyr (363) of RnolV are sug- 
gested to be class IV-specific changes by affecting both sub- 
strate and coenzyme binding [8]. However, the corresponding 
amino acids for Hsa7 are Arg (48), Val (294), and Asn (363) and 
the three residues are not shared by the two class IV ADHs. 
Having two class IV proteins, RnolV and Hsa7, it is of 
interest to identify class IV-specific amino acid changes. Table 
1 shows polymorphic residues, where (i) amino acid changes of 
at least one of the two class IV proteins are not shared by others 
and (ii) amino acids among other classes of ADHs are either 
identical or belong to the same functional group. Comparing 
all vertebrate ADHs, Hsa7 and RnolV are uniquely distin- 
guished from others by Pro (166), Ser (251), and Cys (317) 
(Table 1). These three and additional amino acid changes in 
Hsa7 and RnolV in Table 1 might have been important in its 
functional differentiation from class I ADH. 
Acknowledgements: This work was supported by the National Institute 
of Health Grant AA-03539. 
References 
[1] Smith, M. (1986) Adv. Hum. Genet. 14, 249-290. 
[2] Eklund, H., Branden, C.-I. and Jornvall, H. (1976) J. Mol. Biol. 
102, 61-73. 
[3] Yokoyama, S., Yokoyama, R., Kinlaw, C.S. and Harry, D.E. 
(1990) Mol. Biol. Evol. 7, 143-154. 
[4] Moreno, A. and Pares, X. (1991) J. Biol. Chem. 266, 1128-1133. 
[5] Yasunami, M., Chen, C.-S. and Yoshida, A. (1991) Proc. Natl. 
Acad. Sci. USA 88, 7610-7614. 
[6] Yokoyama, S. and Harry, D.E. (1993) Mol. Biol. Evol. 10, 1215 
1226. 
S. Yokoyama et al. IFEBS Letters 351 (1994) 411415 415 
[7] Sun, H.-W. and Plapp, B. (1992) J. Mol. Evol. 34, 522-535. 
[8] Pares, X., Cederlund, E., Moreno, A., Hjelmqvist, L., Farres, 
J. and Jornvall, H. (1994) Proc. Natl. Acad. Sci. USA 91, 1893- 
1897. 
[9] Matsuo, Y. and Yokoyama, S. (1990) Am. J. Hum. Genet. 46, 
85-91. 
[10] Yokoyama, S., Yokoyama, R. and Rotwein, P. (1987) Jpn. 
J. Genet. 62, 241-256. 
[11] Ochman, H., Medhora, M.M., Garza, D. and Hartl, D.L. (1990) 
in: PCR protocols: a guide to methods and applications (Innis, 
M.A., Gelfand, D.H., Sninsky, J.J. and White, T.J., Eds.) pp. 
219-227, Academic Press, New York. 
[12] Matsuo, Y., Yokoyama, R. and Yokoyama, S. (1989) Eur. J. Bio- 
chem. 183, 317-320. 
[13] Matsuo, Y. and Yokoyama, S. (1989) FEBS Lett. 243, 57 60. 
[14] Zheng, Y.-W., Bey, M., Liu, H. and Felder, M.R. (1993) J. Biol. 
Chem. 268, 24933-24939. 
[15] Kimura, M. (1983) The Neutral Theory of Molecular Evolution, 
Cambridge University Press, Cambridge. 
[16] Duester, G., Smith, M., Bilanehone, V.and Hatfield, G. W. (1986) 
J. Biol. Chem. 261, 2027-2033. 
[17] Yokoyama, S., Matsuo, Y., Rajasekharan, S. and Yokoyama, R. 
(1992) Jpn. J. Genet. 67, 167-171. 
[18] von Bahr-Lindstrom, H., Jornvall, H. and Hoog, J.-O. (1991) 
Gene 103, 269-274. 
[19] Hur, M.-W. and Edenberg, H.J. (1992) Gene 121,305-311. 
[20] Eklund, H., Nordstrom, B., Zeppezauer, E., Soderberg, B.-O., 
Tapia, O., Branden, C.-I. and Akeson, A. (1976) J. Mol. Biol. 102, 
27-59. 
[21] Danielsson, O., Atrian, S., Luque, T., Hjelmqvist, L., Gonzalez- 
Duarte, R. and Jornvall, H. (1994) Proc. Natl. Acad. Sci. USA 91, 
4980-4984. 
